DuPont Completes Acquisition of Donatelle Plastics Incorporated  

 

Transaction deepens healthcare offerings in medical device solutions 

WILMINGTON, Del., July 29, 2024 – DuPont (NYSE: DD) today announced that it has completed the previously announced acquisition of Donatelle Plastics (“Donatelle”), a leading medical device contract manufacturer specializing in medical components and devices.

“I’m pleased to welcome the talented Donatelle colleagues to DuPont,” said Jon Kemp, President, DuPont Electronics & Industrial (E&I). “We’re excited to add Donatelle’s best-in-class advanced injection molding manufacturing capabilities, and decades-long customer relationships with large medical device equipment manufacturers to E&I’s healthcare offerings.”

With a workforce of more than 400 employees, Donatelle becomes part of the Industrial Solutions line of business within the Electronics & Industrial segment. The acquisition of Donatelle brings complementary advanced technologies and capabilities including medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, and tool building. Donatelle has a strong financial growth potential with offerings aligned to attractive therapeutic areas including electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation, and orthopedic extremities.  

About DuPont

DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

# # #